Chief Medical Officer

Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025

Spyre Therapeutics announces poster presentations at UEGW 2025

Spyre Therapeutics initiated with bullish view at Deutsche Bank, here's why

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Clinical Trial Associate

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for inflammatory bowel disease and other immune-mediated conditions. The Clinical Trial Associate (CTA) is essential for executing clinical trials, providing support to clinical study teams, managing clinical biospecimens, and ensuring inspection readiness through effective administrative activities.

Sign up with Google

Sign in with Google